Bladder cancer — all decisions

The Board granted a 40 percent disability rating for bladder cancer in remission with urinary incontinence and denied an increased disability rating in excess of 30 percent for asthma.

The Board granted service connection for bladder cancer, finding it to be related to the Veteran's in-service herbicide exposure.

The Board granted an effective date of December 12, 2023, for a 50 percent evaluation of bipolar disorder and remanded the other issues for further development.

The Board granted service connection for bladder cancer, diabetes mellitus, type 2, and an acquired psychiatric disability (unspecified depressive disorder), but denied a compensable rating for bilateral hearing loss.

The Board granted service connection for the Veteran's cause of death, bladder cancer, due to in-service exposure to ionizing radiation.

The Board denied a higher rating for the residuals of bladder cancer but granted an earlier effective date for service connection.

The Board remands the claim for service connection of bladder cancer to obtain an adequate VA TERA opinion and provide a clarifying opinion on the relationship between exposure to fuel or CARC and bladder cancer.

The Board granted service connection for bladder cancer, finding it at least as likely as not related to the Veteran's military service.

The Board denied the Veteran's claims for a higher disability rating for bladder cancer and prostate cancer, finding that the evidence did not support ratings in excess of 40 percent.

The Board granted service connection for urinary bladder cancer under the PACT Act and remanded other claims for further development.

The Board remands the claims for service connection for prostate cancer and bladder cancer due to a duty to assist error, requiring further medical examination that considers all toxic exposure risk activities.

The Board granted a 10 percent disability rating for residuals of bladder cancer from May 1, 2004, to May 25, 2023, and denied a higher rating in excess of 40 percent from May 26, 2023.

The Board granted service connection for residuals of bladder cancer and erectile dysfunction as secondary to the now service-connected bladder cancer.

The Board denied service connection for bladder cancer, finding that the evidence does not support a causal relationship between the Veteran's toxic exposure risk activities and his bladder cancer.

The Board granted an increased rating of 30 percent for voiding dysfunction due to bladder cancer.

The Board denied service connection for hypertension, hypothyroidism, bladder cancer, and voiding dysfunction with urinary incontinence as the evidence did not support a finding of chronic disease during or shortly after service, nor was there any credible evidence linking these conditions to herbicide exposure or other in-service events.

The Board remands the claim for service connection of bladder cancer to the agency of original jurisdiction for further development and consideration, including obtaining a more detailed exposure record and a new medical opinion.

The claim for service connection for bladder cancer was dismissed because the condition was already service-connected with an earlier effective date.

The Board denied the Veteran's claim for a compensable evaluation for bladder cancer as there was no evidence of voiding dysfunction or renal dysfunction, and the GFR was over 90.

The appeal of the proposed decrease in evaluation of bladder cancer from 100 percent to 20 percent and the appeal for service connection for a kidney condition were both dismissed due to untimely notice of disagreement.